Introduction {#s1}
============

Physical activity level and cardiorespiratory fitness are strongly and inversely associated with the risk of cardiovascular-, metabolic-, and aging-related morbidities, as well as premature mortality [@pone.0037887-Physical1]. To alleviate the health burden associated with sedentary behavior and poor fitness, public health recommendations are that adults be physically active at a moderate intensity for 150 minutes per week or at a vigorous intensity for 75 minutes per week [@pone.0037887-US1].

However, there is considerable interindividual variability in the ability to improve one\'s cardiorespiratory fitness and cardiometabolic and diabetes risk factor profile in response to regular exercise. This clear finding of the HERITAGE Family Study has been replicated [@pone.0037887-Bouchard1], [@pone.0037887-Boule1], [@pone.0037887-Leon1], [@pone.0037887-Church1]. A fundamental question is whether there are individuals who experience one or several adverse responses (ARs) in terms of exercise-induced changes in common risk factors. This issue is addressed herein based on data from six exercise intervention studies, with a focus on exercise-induced changes in resting systolic blood pressure (SBP), fasting insulin (FI), HDL-cholesterol (HDL-C), and triglycerides (TG). The studies used for this purpose are: HERITAGE Family Study (HERITAGE), DREW, INFLAME, STRRIDE, University of Maryland Gene Exercise Research Study (MARYLAND), and University of Jyväskylä study (JYVASKYLA).

Methods {#s2}
=======

Data on a maximum of 1687 adults from six studies were available for analysis. These studies will be briefly described, followed by the definition of AR and the statistical procedures employed. More information on each study is available in [Information S1](#pone.0037887.s001){ref-type="supplementary-material"}.

HERITAGE (Health, Risk Factors, Exercise Training And Genetics) Family Study {#s2a}
----------------------------------------------------------------------------

The sample, study design, and exercise training protocol of HERITAGE have been described elsewhere [@pone.0037887-Bouchard2]. Briefly, 473 adults from 99 families of Caucasian descent and 250 Blacks from 105 families or sibships completed the 20-week endurance training program. Parents were 65 years of age or less while offspring ranged in age from 17 to 41 years.

Dose Response to Exercise in Women (DREW) Study {#s2b}
-----------------------------------------------

A complete description of the DREW design and methods and details of the study participants have been published [@pone.0037887-Morss1]. In brief, it was a randomized, dose-response exercise trial with sedentary, high-normal blood pressure, postmenopausal, overweight or obese women (N = 326: 63% White) assigned to either a nonexercise control group or to endurance exercise groups that expended 4, 8, or 12 kcal/kg of body weight per week for a period of 6 months [@pone.0037887-Church1].

Inflammation and Exercise (INFLAME) Study {#s2c}
-----------------------------------------

Sedentary men and women between the ages of 30 and 75 years who had an elevated plasma C-reactive protein (CRP) concentration (≥2.0 mg/L but \<10.0 mg/L) were randomized to an endurance exercise or a control group [@pone.0037887-Thompson1]. Completers (70% Whites) exercised a mean of 204 minutes per week.

Studies of a Targeted Risk Reduction Intervention through Defined Exercise (STRRIDE) {#s2d}
------------------------------------------------------------------------------------

STRRIDE (84% Whites) includes two complementary studies [@pone.0037887-Kraus1], [@pone.0037887-Bateman1]. STRRIDE was composed of 40- to 65-year-old, sedentary, overweight or class 1 obese (BMI 25--35 kg/m^2^), dyslipidemic men and women. They were assigned to one of three aerobic exercise groups and exercised for 6 months. The STRRIDE aerobic training versus resistance training (AT/RT) cohort was very similar to STRRIDE, but only those who were enrolled in endurance exercise programs are included in the present report.

University of Maryland Gene Exercise Research Study (MARYLAND) {#s2e}
--------------------------------------------------------------

Briefly, 160 men and women (100% Whites) ages 50 to 75 years who were sedentary, nondiabetic, and nonsmoking, with no prior history of cardiovascular disease but with one National Cholesterol Education Program lipid abnormality or blood pressure in the prehypertensive range, exercised three times per week for a period of 6 months [@pone.0037887-Wilund1].

University of Jyväskylä Study (JYVASKYLA) {#s2f}
-----------------------------------------

Healthy, sedentary 40- to 67-year-old men and women were recruited [@pone.0037887-Karavirta1]. A total of 206 subjects were randomized to one of four groups. Here we used the data on 25 men and 26 women of the endurance training group and on 30 men and 24 women (all Whites) of the combined endurance and strength training group who exercised for 21 weeks.

Definition of adverse responses {#s2g}
-------------------------------

For the four traits studied, some subjects experienced changes in an opposite, unfavorable direction compared to the expected beneficial effects. This is analogous to an AR pattern. Defining an AR for any given risk factor is a challenge. A robust definition takes into account the measurement error of the trait, including the variance among laboratories or laboratory technicians, and the normal day-to-day biological variation of the trait. The parameter that captures the totality of these sources of variance in a trait is known as the technical error (TE), defined as the within-subject standard deviation as derived from repeated measures (or assays) over a given period of time, as used in the National Health and Nutrition Examination Survey (NHANES) [@pone.0037887-Malina1]. An ancillary study designed to quantify TE for several biological traits was undertaken in HERITAGE. Sixty subjects were measured three times (except for FI) over a period of 3 weeks for each trait [@pone.0037887-Gagnon1], [@pone.0037887-Wilmore1], [@pone.0037887-Wilmore2], [@pone.0037887-Despres1], [@pone.0037887-Skinner1]. TEs and other useful indicators of reproducibility are shown in [Table 1](#pone-0037887-t001){ref-type="table"}. In the case of FI, the assays were performed only twice, and we used other HERITAGE data plus observations from the literature to develop an estimate of TE for FI ([Information S1](#pone.0037887.s001){ref-type="supplementary-material"}). Here, we have conservatively defined an AR as a response beyond 2×TE in a direction indicating a worsening of the risk factor. For the four traits in the present study, twice the value of TE would mean that ARs would be reached if the exercise training-induced increases are ≥10 mm Hg for SBP, ≥0.42 mmol/L for plasma TG, and ≥24 pmol/L for plasma FI or if there is a decrease of ≤0.12 mmol/L for HDL-C. These AR definitions are used in the remainder of this report.

10.1371/journal.pone.0037887.t001

###### Reproducibility of Risk Factors from Measurements Repeated Over 3 Days on 60 Subjects.

![](pone.0037887.t001){#pone-0037887-t001-1}

  Variable                                                    Mean ± SD (at first test)     CV        ICC             TE
  ---------------------------------------------------------- --------------------------- -------- ------------ -----------------
  Stature, cm                                                         171.7±8.3            0.2        1.00            0.3
  Body weight, kg                                                     71.5±12.8            0.9        1.00            0.7
  Fasting insulin[\*](#nt104){ref-type="table-fn"}, pmol/L            65.8±40.0           19--29   0.78--0.94   13.2--19.8 (12)
  HDL-C, mmol/L                                                       1.08±0.25            6.0        0.94           0.06
  Triglycerides, mmol/L                                               1.04±0.47            21.8       0.79           0.21
  Systolic BP, mm Hg                                                 118.7±10.3            4.1        0.76            4.9

ICC = intraclass correlation computed from the within-subject variance compared to the overall measurement variance.

TE = technical error defined by the within-subject standard deviation calculated from repeated measurements. It includes a combination of measurement error plus day-to-day variation.

CV = Coefficients of variation is expressed as a percentage and is derived from the technical error and the measurement mean.

Note on insulin: The values reported here are from the repeated measurements obtained at baseline (N = 779) and after (N = 624) the exercise program in HERITAGE ([Information S1](#pone.0037887.s001){ref-type="supplementary-material"}). The TE used for this report is shown in parentheses.

To convert pmol/L of insulin to mU/L, divide by 6.945. To convert mmol/L of HDL-C to mg/dL, divide by 0.02586. To convert mmol/L of triglycerides to mg/dl, divide by 0.01129.

Statistical procedures {#s2h}
----------------------

Data are expressed as means and standard deviations or standard errors as specified. Intraclass correlations were computed from the within-subject variance relative to the overall measurement variance. The coefficient of variation is expressed as a percentage and is derived from the TE relative to the measurement mean. The significance of the gains in VO~2~max and of the mean changes in the four targeted risk factors within each cohort was assessed with paired t tests. The comparisons of VO~2~max gains between adverse responders and non-adverse responders for each risk factor trait for each study was undertaken as follows: The difference between the changes in VO~2~max with exercise training expressed in ml O~2~ per minute was tested with the general linear model and is reported as least squares (LS) means with age, sex, and baseline VO~2~max as covariates. The gain in VO~2~max % is reported as LS means with age and sex as covariates.

Results {#s3}
=======

Subjects in DREW, INFLAME, STRRIDE, MARYLAND, and JYVASKYLA were about 20 years older than HERITAGE Whites and Blacks ([Table 2](#pone-0037887-t002){ref-type="table"}). All cohorts had a mean BMI in the overweight range (i.e., \>25.0 but \<30.0 kg/m^2^), with the exception of DREW and INFLAME, with mean values of about 31 kg/m^2^. Mean baseline VO~2~max was considerably lower in DREW and INFLAME compared to the other studies. The mean increase in VO~2~max (ml O~2~ per minute) ranged from 108 (DREW) to 395 (HERITAGE Whites). The percent increase of VO~2~max ranged from 8.7% (DREW) to 18.9% (HERITAGE Blacks).

10.1371/journal.pone.0037887.t002

###### Descriptive Data, Including Baseline O~2~max and its Response to Training, for the Six Cohorts.
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                                HERITAGE Whites   HERITAGE Blacks      DREW        INFLAME       STRRIDE      MARYLAND      JYVASKYLA
  ---------------------------- ----------------- ----------------- ------------ ------------- ------------- ------------- -------------
  Maximum number of subjects          473               250            326           70            303           160           105
  Age, yrs                        35.8 (14.5)       33.6 (11.5)     57.9 (6.5)    51.2 (10)    51.0 (7.7)    58.0 (5.8)    53.5 (7.6)
  Baseline BMI, kg/m^2^           25.8 (4.9)        27.8 (5.8)      31.5 (3.9)   31.1 (4.3)    29.9 (2.9)    28.3 (4.6)    25.4 (3.1)
  BaselineO~2~max, mL/min         2458 (740)        2086 (629)      1312 (240)   1629 (567)    2466 (694)    2060 (536)    2262 (616)
  BaselineO~2~max, mL/kg/min      33.2 (8.9)        27.3 (7.3)      15.8 (2.5)   19.0 (5.6)    28.2 (6.0)    25.3 (4.6)    29.8 (6.2)
  O~2~max response, mL/min         395 (215)         362 (171)      108 (132)     204 (213)     281 (273)     250 (228)     259 (223)
  O~2~max response, %             16.9 (9.0)        18.9 (10.3)     8.7 (10.5)   14.1 (13.5)   12.0 (12.0)   12.3 (10.1)   13.0 (11.7)

Values are given as mean (SD). O~2~max response = post-training O~2~max minus baseline O~2~max (positive value represents improvement in O~2~max).

All gains in VO~2~max are significant at p\<0.05.

Baseline values and the mean (±SD) changes of the risk factors in response to exercise programs are shown in [Table 3](#pone-0037887-t003){ref-type="table"} for each cohort. There was a wide range of baseline values for all risk factors. For instance, mean baseline HDL-C levels ranged from 1.04 mmol/L (HERITAGE Whites) to about 1.50 mmol/L (INFLAME and all DREW exercise groups). The mean changes induced by the exercise programs were generally in the expected direction (i.e., decreases in FI, TG, and SBP and increases in HDL-C). There were, however, some statistically nonsignificant exceptions to these general trends.

10.1371/journal.pone.0037887.t003

###### Baseline and training-induced changes in the four risk factors for the five cohorts (mean ± SD).
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                                                        HERITAGE                                         DREW                         INFLAME                       STRRIDE                                      Maryland                                     Jyvaskyla                                                                                                                 
  ----------------------------------- --------------------------------------------- ---------------------------------------------- ------------- --------------------------------------------- -------------------------------------------- --------------------------------------------- ---------------------------------------------- ---------------------------------------------- --------------------------------------------
  Baseline fasting insulin, pmol/L                      65.7±40.0                                     79.7±63.2                      74±41.24                     75.85±42.34                                  70.93±41.08                                   82.30±40.77                                    −65.3±41.8                                       83±31                                       31.6±16.7
  Change in fasting insulin, pmol/L    −5.2±24.9[†††](#nt110){ref-type="table-fn"}   −10.8±44.6[†††](#nt110){ref-type="table-fn"}   −2.02±31.06   −7.98±27.59[†](#nt108){ref-type="table-fn"}                  −1.95±29.54                                   −5.58±31.33                   −11.6±29.1[†††](#nt110){ref-type="table-fn"}     −11±21[†††](#nt110){ref-type="table-fn"}                     −3.2±14.0
  Baseline HDL-C, mmol/L                                1.04±0.26                                     1.09±0.32                      1.50±0.38                     1.49±0.40                                    1.50±0.35                                     1.50±0.39                                     1.17±0.35                                      1.24±0.41                                     1.28±0.40
  Change in HDL-C, mmol/L              0.04±0.12[†††](#nt110){ref-type="table-fn"}   0.03±0.13[†††](#nt110){ref-type="table-fn"}    −0.01±0.21                    −0.01±0.21                                    −0.04±0.20                   −0.05±0.14[††](#nt109){ref-type="table-fn"}                    0.04±0.16                     0.08±0.21[†††](#nt110){ref-type="table-fn"}                    0.01±0.21
  Baseline Tg, mmol/L                                   1.38±0.78                                     1.04±0.62                      1.45±0.67                     1.47±0.68                                    1.44±0.81                                     1.28±0.56                                     1.72±0.89                                      1.67±1.08                                     1.19±0.71
  Change in Tg, mmol/L                                 −0.02±0.42                                     −0.03±0.41                    −0.08±0.47                    −0.02±0.50                                    0.03±0.56                                     0.00±0.46                    −0.24±0.64[††](#nt109){ref-type="table-fn"}    −0.21±0.74[†††](#nt110){ref-type="table-fn"}   −0.11±0.54[†](#nt108){ref-type="table-fn"}
  Baseline SBP, mm Hg                                  116.2±10.9                                     122.8±12.0                    138.9±13.4                    139.9±13.6                    138.5±12.7[†](#nt108){ref-type="table-fn"}                   131.3±20.4                                        N/A                                          133 + 16                                     131.7±15.6
  Change in SBP, mm Hg                                   0.2±6.2                       −1.2±7.8[†](#nt108){ref-type="table-fn"}       1±12.7                       −1.6±15.1                                    −3.1±11.8                     −4.3±13.8[†](#nt108){ref-type="table-fn"}                        N/A                                           1 + 13                      −3.7±10.9[††](#nt109){ref-type="table-fn"}

p≤0.05.

p\<0.01.

p\<0.001 indicates significant change score within a group.

To convert pmol/L of insulin to mU/L, divide by 6.945. To convert mmol/L of HDL-C to mg/dL, divide by 0.02586. To convert mmol/L of triglycerides to mg/dl, divide by 0.01129.

Using the definitions outlined in [Table 1](#pone-0037887-t001){ref-type="table"}, the prevalence of ARs for the four risk factors was first explored in the 473 Whites and 250 Blacks of HERITAGE who were all exposed to the same standardized exercise programs and were all qualified as completers. The results are depicted in [Figure 1](#pone-0037887-g001){ref-type="fig"} and are summarized in [Table 4](#pone-0037887-t004){ref-type="table"}. Although HERITAGE subjects were apparently healthy and not taking medication for blood pressure, glucose, or lipid anomalies and were exposed to the same exercise program, 6% to 9% of Blacks and Whites experienced ARs for each of the four risk factors, with no substantive differences between the two ethnic groups.

![Distribution of the response to the HERITAGE exercise program with adverse responders highlighted in red.\
To convert pmol/L of insulin to mU/L, divide by 6.945. To convert mmol/L of HDL-C to mg/dL, divide by 0.02586. To convert mmol/L of triglycerides to mg/dl, divide by 0.01129.](pone.0037887.g001){#pone-0037887-g001}

10.1371/journal.pone.0037887.t004

###### Prevalence of Adverse Responders in HERITAGE.
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                                       HERITAGE Whites (≤473)   HERITAGE Blacks (≤250)       
  ------------------- --------------- ------------------------ ------------------------ ---- ---
  Δ Fasting insulin     N≥24 pmol/L              38                       9              17   9
  Δ HDL-C              N≤0.12 mmol/L             28                       6              19   8
  Δ Triglycerides      N≥0.42 mmol/L             37                       8              19   8
  Δ Systolic BP         N≥10 mm Hg               28                       6              16   7

To convert pmol/L of insulin to mU/L, divide by 6.945. To convert mmol/L of HDL-C to mg/dL, divide by 0.02586. To convert mmol/L of triglycerides to mg/dl, divide by 0.01129.

To gain a better understanding of the true prevalence of ARs for each risk factor, we compared the data obtained in HERITAGE with those of five other exercise training studies. The results are summarized in [Table 5](#pone-0037887-t005){ref-type="table"}. It is quite obvious that the findings in HERITAGE are not unique to the HERITAGE subjects and exercise protocol. Based on a maximum of 1687 subjects, the prevalence of an AR reached 8.3% for the changes in FI, 13.3% for the changes in fasting HDL-C, 10.3% for TG, and 12.2% for resting SBP. The percentages of adverse responders for each trait for each study are depicted in [Figure 2](#pone-0037887-g002){ref-type="fig"}. It is remarkable that such cases were found in each study, even though the age and health status of the subjects were widely divergent and the exercise programs were quite heterogeneous.

![Percentages of adverse responders for each risk factor trait by study, with number of adverse responder subjects in each bar.](pone.0037887.g002){#pone-0037887-g002}

10.1371/journal.pone.0037887.t005

###### Prevalence of Adverse Responders to Regular Exercise in Six Studies.
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                       HERITAGE   DREW   INFLAME   STRRIDE   MARYLAND   JYVASKYLA   TOTAL   \%[\*](#nt113){ref-type="table-fn"}
  ------------------- ---------- ------ --------- --------- ---------- ----------- ------- -------------------------------------
  N subjects             ≤723     ≤326     ≤70      ≤303       ≤160       ≤105      ≤1687  
  Δ Fasting insulin       55       36      12        17         4           2        126                    8.3
  Δ HDL-C                 47       87      21        32         8          27        222                   13.3
  Δ Triglycerides         56       51       9        34         11         11        172                   10.3
  Δ Systolic BP           44       58      11        NA         43         10        166                   12.2

\% represents the proportion of adverse responders in relation to the total number of subjects exercise trained for each of the four traits.

One important question to consider is whether those who respond adversely for a given risk factor are also those who experience the least improvement in cardiorespiratory fitness with regular exercise. This question was addressed by comparing the gains in VO~2~max between the subgroups of adverse responders and non-adverse responders for a given risk factor. The results of these analyses are shown in [Table 6](#pone-0037887-t006){ref-type="table"} for the gains in ml O~2~ per minute and the percentage increases in VO~2~max. A total of 56 differences were tested with age, sex, and baseline VO~2~max as covariates for the gain in ml O~2~ per minute and age and sex for the percentage increase. Only two such differences reached the 0.05 level of significance, and they were far from reaching a multiple test Bonferroni adjusted *P* value of 0.0009. These data indicate that AR traits are independent of the improvement in cardiorespiratory fitness.

10.1371/journal.pone.0037887.t006

###### Comparison of the VO2max response to regular exercise between adverse responders and non-adverse responders for each response trait in each study.
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                           HERITAGE Whites   HERITAGE Blacks      DREW       INFLAME                                         
  ----------------------- ----------------- ----------------- ------------ ------------ ----------- ----------- ------------ ------------
  **Δ Fasting insulin**                                                                                                      
  N subjects                     38                411             17          184          36          290          12           58
  Δ VO~2~max (ml/min)         382 (34)          399 (10)        472 (43)     385 (14)     76 (22)     69 (7)      99 (61)      226 (28)
  Δ VO~2~max (%)             16.1 (1.4)        17.0 (0.4)      20.6 (2.5)   18.3 (0.8)   6.0 (1.7)   5.8 (0.6)   8.0 (3.4)    14.5 (1.6)
  **Δ HDL-C**                                                                                                                
  N subjects                     28                443             19          220          87          239          21           49
  Δ VO~2~max (ml/min)         384 (40)          400 (10)        348 (39)     388 (12)     68 (14)      71(8)      219 (48)     196 (32)
  Δ VO~2~max (%)             16.2 (1.7)        17.0 (0.4)      15.5 (2.3)   18.4 (0.7)   5.4 (1.1)   6.0 (0.7)   14.2 (2.7)   12.9 (1.8)
  **Δ Triglycerides**                                                                                                        
  N subjects                     37                434             19          220          51          275          9            61
  Δ VO~2~max (ml/min)         424 (34)          397 (10)        332 (39)     392 (13)     72 (18)     70 (8)      136 (72)     213 (28)
  Δ VO~2~max (%)             17.7 (1.4)        16.9 (0.4)      16.9 (2.3)   18.3 (0.7)   6.1 (1.5)   5.8 (0.6)   8.6 (4.0)    14.0 (1.6)
  **Δ Systolic BP**                                                                                                          
  N subjects                     28                442             16          220          58          268          11           59
  Δ VO~2~max (ml/min)         348 (40)          401 (10)        396 (42)     386 (12)     60 (17)     72 (8)      140 (65)     215 (28)
  Δ VO~2~max (%)             14.8 (1.7)        17.0 (0.4)      16.7 (2.5)   18.2 (0.7)   4.9 (1.4)   6.1 (0.6)   7.5 (3.6)    14.4 (1.6)

                            STRRIDE      MARYLAND    JYVASKYLA                                                            
  ----------------------- ------------ ------------ ------------ ------------ ------------------------------------------- ------------
  **Δ Fasting insulin**                                                                                                   
  N subjects                   17          286           4            92                           2                           57
  Δ VO~2~max (ml/min)      278 (102)     278 (16)    112 (102)     306 (21)                    340 (158)                    277 (30)
  Δ VO~2~max (%)           10.5 (3.6)   11.7 (0.7)   7.7 (5.0)    15.1 (1.0)                  12.7 (8.8)                   14.2 (1.6)
  **Δ HDL-C**                                                                                                             
  N subjects                   32          271           8           142                          26                           71
  Δ VO~2~max (ml/min)       231 (41)     281 (17)     206 (72)     274 (17)    183 (42)[†](#nt116){ref-type="table-fn"}     287 (26)
  Δ VO~2~max (%)           11.4 (2.6)   11.6 (0.7)   10.0 (3.4)   13.4 (0.8)   8.1 (2.2)[†](#nt116){ref-type="table-fn"}   14.7 (1.3)
  **Δ Triglycerides**                                                                                                     
  N subjects                   34          269           11          141                          11                           86
  Δ VO~2~max (ml/min)       201 (46)     281 (17)     276 (62)     272 (17)                    285 (67)                     256 (24)
  Δ VO~2~max (%)           8.3 (1.9)    12.1 (0.7)   13.4 (3.0)   13.3 (0.8)                  12.3 (3.5)                   13.0 (1.3)
  **Δ Systolic BP**                                                                                                       
  N subjects                  N/A          N/A           43          115                          10                           87
  Δ VO~2~max (ml/min)         N/A          N/A        230 (31)     271 (19)                    244 (70)                     261 (24)
  Δ VO~2~max (%)              N/A          N/A       12.3 (1.5)   13.1 (0.9)                  12.9 (3.7)                   13.0 (1.2)

Data expressed as means and standard deviations.

Δ VO2max expressed as the change with exercise training in ml O2 per minute, reported as LS means with age, sex, and baseline VO2max as covariates. Δ VO2max % reported as LS means with age and sex as covariates.

p≤0.05 indicates significant difference in VO2max training response between adverse responders and non-adverse responders.

One could hypothesize that the proportion of ARs should decrease as the amount of exercise increases. We tested this hypothesis with the data of DREW, and the results are summarized in [Table 7](#pone-0037887-t007){ref-type="table"}. No substantive differences were observed in the prevalence of ARs among the three levels of exercise energy expenditure, which ranged from 4 to 12 kcal/kg of body weight per week.

10.1371/journal.pone.0037887.t007

###### Adverse and Excellent Responders to Regular Exercise in DREW[\*](#nt117){ref-type="table-fn"}.
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                                       DREW4 kcal/kg/wk   DREW8 kcal/kg/wk   DREW12 kcal/kg/wk            
  ------------------- --------------- ------------------ ------------------ ------------------- ---- ---- ----
  Δ Fasting insulin     N≥24 pmol/L           16                 11                  9           10   11   12
  Δ HDL-C              N≤0.12 mmol/L          35                 25                 21           24   31   33
  Δ Triglycerides      N≥0.42 mmol/L          19                 13                 14           16   18   19
  Δ SBP                 N≥10 mm Hg            32                 22                 14           16   12  

A postmenopausal woman who follows the *2008 Physical Activity Guidelines for Americans* expends about 8 kcal/kg/week in her exercise program. The 4 kcal/kg/week is about 50% the current recommendation whereas the 12 kcal/kg/week is about 50% above the recommended dose.

Another important question is that of the proportion of subjects who experienced ARs for more than one risk factor. We tabulated the number of participants in the six studies who registered ARs for two or more risk factors, and the results are shown in [Table 8](#pone-0037887-t008){ref-type="table"}. Approximately 7% of sedentary adults experienced ARs for at least two common cardiometabolic and diabetes risk factors following exposure to regular exercise. Only a small minority of participants (\<1%) exhibited ARs for three or more traits.

10.1371/journal.pone.0037887.t008

###### Percentage of Subjects in Each Study with 1, 2, or 3 and More Adverse Responses.
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                     1 Adverse Response   2 Adverse Responses   3 or 4 Adverse Responses             
  ----------------- -------------------- --------------------- -------------------------- ----- ---- ------
  HERITAGE                                                                                           
  Blacks                     51                   20%                      11              4%    0     0%
  Whites                     94                   20%                      17              4%    3     1%
  DREW                      131                   40%                      37              11%   9     3%
  INFLAME                    32                   46%                      9               13%   1     1%
  STRRIDE                    71                   24%                      9               3%    0     0%
  MARYLAND                   54                   34%                      5               3%    0     0%
  JYVASKYLA                  35                   33%                      7               7%    0     0%
  TOTALS (mean %)           468                   31%                      95              6%    13   0.8%

The four traits considered were the exercise training-induced changes in fasting insulin, HDL-cholesterol, triglycerides, and resting systolic blood pressure.

Discussion {#s4}
==========

The prevalence of ARs for select risk factors varied from 8.3% for the exercise training-induced changes in FI to 13.3% for the changes in HDL-C, with about 7% of participants experiencing adverse changes in two or more risk factors. This subgroup should receive urgent attention. The prevalence of ARs appears to be similar at low and high doses of exercise. However, we do not know whether some adverse responders would revert to a more positive response pattern if exposed to different exercise doses or exercise modalities.

It is important to differentiate between ARs for risk factors for common chronic diseases, as referred to in the present study, from other more acute ARs such as cardiac events related to exertion during an exercise bout [@pone.0037887-Siscovick1], [@pone.0037887-Thompson2], [@pone.0037887-Kim1], sudden cardiac death during or immediately after exercise typically associated with a cardiomyopathy or a congenital abnormality [@pone.0037887-Thompson3], or even exercise intolerance due to abnormal skeletal muscle energy metabolism [@pone.0037887-Rankinen1]. These events are fortunately rare among physically active people. In contrast, ARs as defined herein for common cardiometabolic and diabetes risk factors are much more prevalent and become evident with exposure to regular exercise. It is not known whether such ARs can be detected after a single or a few bouts of exercise.

Even though the presence of ARs was first detected among completers in Blacks and Whites of the HERITAGE Family Study, in which subjects were confirmed to be sedentary at baseline, with a rather healthy profile, the phenomenon was confirmed in five other exercise intervention studies. The consistency in the prevalence of ARs across heterogeneous studies in terms of health status of subjects at baseline and of exercise training regimen is notable.

One question that may arise is whether ARs are the result of unwarranted exercise-drug interaction effects. The question cannot be answered with direct experimental data at the moment, but based on our analysis of the results of the six studies, it is highly unlikely that it is the case. For instance, HERITAGE and JYVASKYLA subjects were healthy adults taking no medication for high blood pressure, hypercholesterolemia, or hyperglycemia. However, many subjects in DREW, INFLAME, MARYLAND, and STRRIDE were taking medications for high blood pressure, hyperglycemia, or dyslipoproteinemia. Yet substantial numbers of subjects with or without medication in these cohorts experienced one or more ARs.

The challenge is now to investigate whether baseline predictors of ARs can be identified to screen individuals at risk so that they can be offered alternative approaches to modifying cardiometabolic risk factors. Research based on HERITAGE has amply demonstrated that the response pattern to exercise training aggregates in families [@pone.0037887-Bouchard3], [@pone.0037887-Rice1], [@pone.0037887-Katzmarzyk1], [@pone.0037887-Hong1]. In fact, the heritability of the changes induced by the exercise program reached about 30% for plasma HDL-C and TG [@pone.0037887-Rice1] and about 20% to 25% for indicators of insulin metabolism and resting SBP [@pone.0037887-An1], [@pone.0037887-Rice2]. There are strong indications from a baseline skeletal muscle gene expression profile and from a genome-wide association study performed on the Whites of HERITAGE that the genetic component of a response trait can be defined in terms of RNA abundance observed in the sedentary state or by specific genomic variants [@pone.0037887-Bouchard4], [@pone.0037887-Timmons1], [@pone.0037887-Rankinen2]. This suggests that it may be possible with further research to identify molecular predictors of the inability to benefit from regular exercise and of adverse changes in specific cardiometabolic and diabetes risk factors.

In summary, we did not find any evidence for differences in the prevalence of ARs between Blacks and Whites or between men and women. Moreover, the AR traits are not explained by prior health status of subjects, age, amount of exercise imposed by the program, or lack of improvement in cardiorespiratory fitness. No evidence could be found for the hypothesis that ARs were the result of drug-exercise interactions. Thus, some individuals experience ARs when exposed to regular exercise, but the causes of the phenomenon are unknown at this time. The observations reported herein need to be extended to other cardiometabolic and diabetes risk factors such as LDL-cholesterol, small, dense LDL particles, markers of low-grade inflammation, adiposity traits, and ectopic fat depots. We conclude that it is critical to search for potential physiological and molecular predictors so that individuals at risk for adverse response patterns can be identified and offered proper guidance in an exercise medicine preventive or therapeutic context.
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